37 results
8-K
EX-99.1
f8su6gkwlcndb p99v1
8 Aug 23
MAIA Biotechnology Reports Second Quarter 2023 Financial Results and Provides Updates for THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:15am
DRS
dhr o5ic6a
1 Jun 23
Draft registration statement
12:00am
8-K
EX-99.1
rvnjv091
8 May 23
MAIA Biotechnology Reports First Quarter 2023 Financial Results and Provides Corporate Update
8:15am
424B4
qc5jfh8q
25 Apr 23
Prospectus supplement with pricing info
7:45pm
DEF 14A
qhe9k6v9 euq
19 Apr 23
Definitive proxy
4:06pm
DRS
p7p yyjpj
23 Dec 22
Draft registration statement
12:00am